Mind Medicine (MindMed) Inc. (MNMD)
NASDAQ: MNMD · Real-Time Price · USD
6.45
+0.30 (4.88%)
At close: May 12, 2025, 4:00 PM
6.48
+0.03 (0.47%)
After-hours: May 12, 2025, 7:35 PM EDT
Mind Medicine (MindMed) Stock Forecast
Stock Price Forecast
According to 8 professional analysts, the 12-month price target for Mind Medicine (MindMed) stock ranges from a low of $14 to a high of $55. The average price target of $25.75 forecasts a 299.22% increase in the stock price over the next year.
Price Target: $25.75 (+299.22%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Mind Medicine (MindMed) stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 4 |
| Buy | 4 | 5 | 5 | 5 | 5 | 5 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 10 | 10 | 10 | 10 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Strong Buy Maintains $20 | Strong Buy | Maintains | $20 | +210.08% | May 9, 2025 |
| Baird | Baird | Buy Maintains $27 → $16 | Buy | Maintains | $27 → $16 | +148.06% | Mar 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $55 | Strong Buy | Reiterates | $55 | +752.71% | Mar 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $55 | Strong Buy | Reiterates | $55 | +752.71% | Jan 31, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Initiates $23 | Buy | Initiates | $23 | +256.59% | Jan 28, 2025 |
Financial Forecast
Revenue This Year
n/a
from 602.35M
Revenue Next Year
n/a
EPS This Year
-1.60
from -1.54
EPS Next Year
-1.74
from -1.60
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | n/a | 109.5M | ||
| Avg | n/a | n/a | 43.4M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.48 | -1.54 | -1.37 | ||
| Avg | -1.60 | -1.74 | -1.53 | ||
| Low | -1.64 | -1.87 | -1.88 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.